Agenda

Return

C. 97

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	January 5, 2021

Contra

Costa

County

Subject:

Purchase Order with Vigilanz Corporation

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 01/05/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Irene Segovia Marcy Wilhelm

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: January 5, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent, on behalf of the Health Services Director, to execute (1) a purchase order with VigiLanz Corporation, in the amount not to exceed $400,990 for the renewal of Dynamic Monitoring Suite software maintenance, support and hosting for the period January 1, 2021 through December 31, 2025 and (2) a Software as a Service (SaaS) License Agreement for the term of January 1, 2021 through December 31, 2025.

FISCAL IMPACT:

Approval will result in total expenditures of up to $400,990 over a five year period and will be 100% funded by the Hospital Enterprise Fund I.

BACKGROUND:

VigiLanz Dynamic Monitoring Suite is a complete real-time decision support and care management solution for our clinical pharmacies. VigiLanz helps clinical pharmacists conduct more thorough medication real-time oversight to identify, anticipate and prevent Adverse Drug Events (ADEs). VigiLanz provides the solution through a software as a service (SaaS) arrangement and hosts the software and data. VigiLanz has been an invaluable and critical tool for over a decade in meeting California Department of Public Health (CDPH), Centers for Medicare and Medicaid Services (CMS) and the Joint Commission (JC) requirements pertaining to medication management compliance as well as enabling us to be fully in compliance with Antimicrobial Stewardship Program laws.

CONSEQUENCE OF NEGATIVE ACTION:

If this action is not approved, clinical pharmacists will not have access to medication support tools provided by the VigiLanz Dynamic Monitoring Suite to ensure compliance with CDPH, CMS and JC requirements.